ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $659,148 | -4.6% | 31,629 | +9.6% | 0.10% | -7.2% |
| Q2 2023 | $691,101 | +16.1% | 28,856 | -8.7% | 0.11% | -33.9% |
| Q1 2023 | $595,013 | +116.1% | 31,616 | +82.8% | 0.17% | +257.4% |
| Q4 2022 | $275,289 | -44.2% | 17,292 | -42.6% | 0.05% | -48.9% |
| Q3 2022 | $493,000 | +150.3% | 30,118 | +115.3% | 0.09% | +100.0% |
| Q2 2022 | $197,000 | -65.3% | 13,987 | -40.3% | 0.05% | -70.5% |
| Q1 2022 | $568,000 | +159.4% | 23,448 | +149.7% | 0.16% | +164.4% |
| Q4 2021 | $219,000 | -42.7% | 9,389 | +31.3% | 0.06% | -56.9% |
| Q4 2020 | $382,000 | -40.7% | 7,153 | -54.2% | 0.14% | -49.4% |
| Q3 2020 | $644,000 | +199.5% | 15,616 | +251.3% | 0.27% | +153.3% |
| Q2 2020 | $215,000 | +1691.7% | 4,445 | +519.1% | 0.11% | +94.5% |
| Q4 2018 | $12,000 | – | 718 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |